🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study compares patient symptoms and anterior segment safety in patient...
Status
Completed
Location
Multiple Locations
Start Date
2008-11
Trial ID
NCT00804648
Treatments Being Tested
The purpose of this study is to assess the safety and efficacy of Timolol 0...
Status
Completed
Location
Ann and Robert H. Lurie Children's Hospital of Chicago
Start Date
2017-05-05
Trial ID
NCT02913612
Treatments Being Tested
The purpose of this study is to determine whether a glaucoma therapy is saf...
Status
Completed
Location
United States Investigative Sites in Texas and Other States
Start Date
2005-11
Trial ID
NCT00287521
The goal of this clinical trial is: 1)To evaluate the pharmacokinetic prof...
Status
Completed
Location
Huzhou Central Hospital
Start Date
2024-06-15
Trial ID
NCT06813807
Treatments Being Tested
Topical timolol has been used primarily as eye drops to treat glaucoma for ...
Status
Completed
Location
VA Northern California Health Care System
Start Date
2017-11-21
Trial ID
NCT04903366
Treatments Being Tested
The purpose of this study is to determine whether Timolol 0.5% Gel Forming ...
Status
Withdrawn
Location
Children's Hospital of Philadelphia
Start Date
2011-02
Trial ID
NCT01408056
Treatments Being Tested
The purpose of the study is to compare the safety and intraocular pressure-...
Status
Completed
Location
Contact Alcon Call Center at 1-888-451-3937
Start Date
2007-11
Trial ID
NCT00620256
The purpose of this study is to evaluate the safety and efficacy of BETOPTI...
Status
Completed
Location
Alcon Call Center
Start Date
2003-01
Trial ID
NCT00061542
Treatments Being Tested
Primary Objective: • To assess the possible utility of topical timolol in ...
Status
Terminated
Location
Wills Eye Institute
Start Date
2012-02
Trial ID
NCT01533376
Treatments Being Tested